Literature DB >> 28689782

The microbiota and autoimmunity: Their role in thyroid autoimmune diseases.

Hedda L Köhling1, Sue F Plummer2, Julian R Marchesi3, Kelly S Davidge4, Marian Ludgate5.   

Abstract

Since the 1970s, the role of infectious diseases in the pathogenesis of Graves' disease (GD) has been an object of intensive research. The last decade has witnessed many studies on Yersinia enterocolitica, Helicobacter pylori and other bacterial organisms and their potential impact on GD. Retrospective, prospective and molecular binding studies have been performed with contrary outcomes. Until now it is not clear whether bacterial infections can trigger autoimmune thyroid disease. Common risk factors for GD (gender, smoking, stress, and pregnancy) reveal profound changes in the bacterial communities of the gut compared to that of healthy controls but a pathogenetic link between GD and dysbiosis has not yet been fully elucidated. Conventional bacterial culture, in vitro models, next generation and high-throughput DNA sequencing are applicable methods to assess the impact of bacteria in disease onset and development. Further studies on the involvement of bacteria in GD are needed and may contribute to the understanding of pathogenetic processes. This review will examine available evidence on the subject.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Bacteria; Graves' disease; Hashimotos's thyroiditis

Mesh:

Year:  2017        PMID: 28689782     DOI: 10.1016/j.clim.2017.07.001

Source DB:  PubMed          Journal:  Clin Immunol        ISSN: 1521-6616            Impact factor:   3.969


  34 in total

1.  Clostridium difficile colitis in the setting of subacute thyroiditis: the chicken or the egg.

Authors:  Jacob Mathew
Journal:  BMJ Case Rep       Date:  2018-12-18

Review 2.  Gut microbiota: a perspective of precision medicine in endocrine disorders.

Authors:  Salman Shirvani Rad; Amirabbas Nikkhah; Mohammadmahdi Orvatinia; Hanieh-Sadat Ejtahed; Negar Sarhangi; Seyed Hamid Jamaldini; Nazli Khodayari; Hamid Reza Aghaei Meybodi; Mandana Hasanzad
Journal:  J Diabetes Metab Disord       Date:  2020-08-12

Review 3.  The risk factors for Graves' ophthalmopathy.

Authors:  Jiamin Cao; Yuhe Su; Zhuokun Chen; Chen Ma; Wei Xiong
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2021-11-17       Impact factor: 3.117

4.  Alterations and Mechanism of Gut Microbiota in Graves' Disease and Hashimoto's Thyroiditis.

Authors:  Hong Zhao; Lijie Yuan; Dongli Zhu; Banghao Sun; Juan Du; Jingyuan Wang
Journal:  Pol J Microbiol       Date:  2022-06-09

Review 5.  Myasthenia gravis and infectious disease.

Authors:  Nils Erik Gilhus; Fredrik Romi; Yu Hong; Geir Olve Skeie
Journal:  J Neurol       Date:  2018-01-25       Impact factor: 4.849

Review 6.  A transgenic mouse that spontaneously develops pathogenic TSH receptor antibodies will facilitate study of antigen-specific immunotherapy for human Graves' disease.

Authors:  Sandra M McLachlan; Basil Rapoport
Journal:  Endocrine       Date:  2019-09-27       Impact factor: 3.633

7.  Fibrosis in dysthyroid eye disease.

Authors:  Marian Ludgate
Journal:  Eye (Lond)       Date:  2019-12-16       Impact factor: 3.775

8.  Cambridge Ophthalmological Symposium 2018: introduction and reflections on the day.

Authors:  Marian Ludgate
Journal:  Eye (Lond)       Date:  2018-12-19       Impact factor: 3.775

9.  Microbiome and Graves' Orbitopathy.

Authors:  Giulia Masetti; Marian Ludgate
Journal:  Eur Thyroid J       Date:  2020-11-05

Review 10.  Celiac Disease and the Thyroid: Highlighting the Roles of Vitamin D and Iron.

Authors:  Christina Starchl; Mario Scherkl; Karin Amrein
Journal:  Nutrients       Date:  2021-05-21       Impact factor: 5.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.